Sapphire Star Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$428K Sell
2,300
-1
-0% -$205 0.57% 68
2018
Q3
$575K Hold
2,301
0.58% 67
2018
Q2
$502K Hold
2,301
0.52% 73
2018
Q1
$441K Buy
2,301
+600
+35% +$111K 0.49% 76
2017
Q4
$266K Sell
1,701
-625
-27% -$98.4K 0.32% 97
2017
Q3
$361K Buy
+2,326
New +$368K 0.47% 42

Other funds holding IDXX

Sapphire Star Partners's IDXX Position: Q4 2018 in Review

Sapphire Star Partners reduced its Idexx Laboratories (IDXX) stake by 0.04% in Q4 2018, selling an estimated $205 and leaving 2,300 shares worth $428K. The position accounts for 0.57% of the portfolio, ranked #68.

Sapphire Star Partners first reported a position in IDXX in Q3 2017 and has held it in 6 quarters since. The position peaked at $575K in Q3 2018. 671 funds tracked by Wall St. Rank hold IDXX as of Q4 2018.

  • Sapphire Star Partners held 2,300 shares of Idexx Laboratories worth $428K as of Q4 2018.
  • Sapphire Star Partners sold 1 Idexx Laboratories share in Q4 2018, an estimated $205.
  • Idexx Laboratories made up 0.57% of Sapphire Star Partners's portfolio in Q4 2018, its #68 holding.
  • Sapphire Star Partners first reported a position in Idexx Laboratories in Q3 2017 and has held it in 6 quarters since.
  • Sapphire Star Partners's Idexx Laboratories position peaked at $575K in Q3 2018.
  • 671 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2018.

Based on Sapphire Star Partners's 13F filing for Q4 2018, filed 12 Feb 2019.